Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DENV-1-LVHC Challenge Model Expansion
NCT03869060Phase 1Completed
- Sponsor
- Upstate Medical University
- Start
- Mar 2019
- Primary completion
- Sep 2019
- Modality
- Oncolytic Viruses, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of DENV-1-LVHC (strain 45AZ5) in dengue fever, sponsored by Upstate Medical University. Primary endpoints: Number, Intensity, and Duration of Abnormal Laboratory Parameters at 28 days, Occurrence, Intensity, and Duration of Solicited and Unsolicited Injection Site Symptoms at 28 days and 2 more. Started Mar 2019; status: completed.
02
Drugs
DENV-1-LVHC (strain 45AZ5)
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT03869060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03869060.